Explore funding opportunities dedicated to driving healthcare innovation. Whether you're developing groundbreaking solutions or leading collaborative research projects, our funding directory highlights valuable support to help bring your ideas to life.
The list below provides an overview of current funding opportunities and is updated regularly. Please note, this is not an exhaustive directory and only highlights a selection of available calls.
Our funding team has access to a comprehensive global database of funding calls and initiatives. If you're seeking a more extensive and tailored search to find the right opportunities for your innovation, we’re here to help.
Contact us at fundingsupport@lshubwales.com for guidance, bid review and editing, and help finding the perfect opportunity for your project. Last updated: November 2025
HABRI advances life-science research on human–animal interaction by funding evidence-based studies on how companion animals influence human health, wellbeing and behaviour. Its programme supports translational, clinically relevant investigations of pet ownership and animal-assisted interventions across diverse populations, species and cultures, generating actionable guidance for healthcare, veterinary and policy stakeholders.
The Daisy Foundation was created in 1999 in memory of Patrick Barnes, to keep his spirit alive and also say a profound thank you to nurses for the extraordinary skill and compassion they provide patients and families every day. Daisy stands for diseases attacking the immune system. Through its Health Equity Grants, the Foundation supports nursing research and evidence-based projects (EBP) with grants to nurses.
Fellowship programme for senior postdoctoral clinical academics in the UK who wish to undertake funded research and take part in a bespoke training and leadership development programme.
Alzheimer's Research UK provides PhD Scholarships to provide a stipend, tuition costs and research/travel costs for a full PhD programme. National or international secondments are supported and encouraged within the scheme.The award is for up to four years and is for the full duration of a PhD programme. Alzheimer's Research UK is open to considering applications for part-time PhD students.
The funding bid supports clinical cancer research projects by academic and non-profit institutions worldwide, focusing on improving patient outcomes, prevention, early detection, and innovative therapies. Eligible projects include interventional clinical trials, early detection studies, and paediatric cancer trials, with mandatory patient involvement. Priority is given to projects showing potential patient impact within five years.
The Oxford–Harrington Rare Disease Scholar Award supports UK-based researchers advancing rare disease discoveries towards clinical impact. Scholars receive £100,000, tailored drug development expertise, and project support. Offered by the Oxford–Harrington Rare Disease Centre, the award also provides access to further funding while allowing researchers to retain full intellectual property rights.
This opportunity is provided by the Oxford-Harrington Rare Disease Centre (OHC), a partnership between the University of Oxford and Harrington Discovery Institute to advance promising discoveries from academic labs to move them into clinical practice. The award combines funding and expert therapeutics development support to help researchers in the UK, US, or Canada to accelerate preclinical projects towards treatments for patients.
The National Institute for Health and Care Research (NIHR) Climate Change and Health Research Collaboration Awards will support research that addresses the challenges of climate change by building resilience into the delivery of health and social care services during severe weather events (made worse by climate change), for example, extreme heat and flooding.
The NIHR Work and Health Research Awards support large-scale, ambitious projects addressing key priorities in work and occupational health. Up to £2 million over three years is available for transdisciplinary teams. Applicants should consult the NIHR Work and Health Logic Model to align proposals with the initiative’s short- and long-term aims.
The NIHR Decarbonising the Health and Social Care System funding opportunity will run annually for a period of five years (2024 to 2028), with total funding of £25 million. The aim is to fund research into decarbonising the health and social care system as part of NIHR's climate health and sustainability commitments to help reduce carbon emissions and achieve net zero.
The funding bid is for a Doctoral and Skills Enhancement (DSE) award, supporting early- to mid-career researchers to gain skills and experience for future NIHR personal awards or research grants. It provides salary for up to 2 years, plus training, development, conference, and mentorship costs, but does not fund practice time.
Funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test or other medical intervention development. This fund will provide small scale funding to generate critical data needed prior to seeking more substantive funding.
The NIHR Work and Health Research Awards fund large, cross-disciplinary projects tackling key issues like long-term conditions, disability, sickness absence, COVID-19 impact, workforce mental health, and health inequalities. Aimed at improving employment and health outcomes, proposals should involve cross-sector teams, support implementation in systems like ICSs, and deliver public benefit.
This call is aimed at supporting novel and transdisciplinary teams to explore this intersection at the earliest stages of research ideation, design and partnership building. Collaborations could take many different forms and centre on a variety of areas of focus.
A very small number of grants are available to UK registered or exempt charities and NHS organisations to expand proven health and care interventions and deliver them more widely within the UK.
Wellcome's Genomics in Context Awards - Collaborative Research at the Intersection of Genomics, Humanities, Social Sciences and Bioethics scheme will fund transdisciplinary teams to drive research breakthroughs at the crossroads of genomics, humanities, social sciences and bioethics. Supported projects will receive dedicated time and resources to shape fresh research directions and experiment with novel approaches to collaboration. This scheme is expected to open in November 2025.
Grants for innovations in bowel cancer diagnosis and screening. It’s not just about discovering new methods — strengthening and enhancing what’s already working is equally important. Proposals must address one of the areas highlighted in Goal 1 of our Research Strategy, which focuses on removing barriers to early and timely diagnosis: Stratify populations based on their risk of developing bowel cancer, with a focus on people with high-risk conditions, improve the sensitivity, acceptability, and coverage of bowel cancer screening tests, enhance the diagnosis of bowel cancer and how the right treatment options are chosen.
Proposals must address the following research question: What is the best step-up treatment for people aged 12 years and older diagnosed with asthma, whose asthma is uncontrolled on a low-dose inhaled corticosteroid/formoterol combination inhaler used as needed?
The funding bid supports research addressing palliative and end-of-life care priorities identified by the James Lind Alliance. It aims to evaluate interventions that enable people to die well at home, support those with multiple conditions, and address the needs of socially isolated individuals. Projects should improve community care, staff and carer skills, care integration, and equitable access to services.
The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer.
The GOSH Charity National Research Programme Grants provide support for ambitious, long-term research programmes that will generate a significant shift in the progress or understanding within an area of rare or complex paediatric disease.
The CRUK research funding programme awards a wide range of fellowships and grants to support researchers, across all career stages, conducting clinical, pre-clinical, discovery and translational research to advance the detection, diagnosis, treatment, and potential cure, of all forms of cancer.
Funding over a maximum period of ten years to support innovative, investigator-led clinical research - incorporating clinical trials, experimental medicine and sample collection - to further understanding of the biology and treatment of cancer.
Funding over two years for researchers and clinical academics based at institutions in the UK to undertake pilot studies and preliminary research on movement and balance disorders in children and young people.
FSHI's Research Grant Development Awards provide pump-priming funds for the development of high-quality, innovative research in areas of the sociology of health and illness. Grants are intended to support groups to produce substantive outputs in the form of a full grant application to a major national or international funding body and, where appropriate, publications in peer-reviewed journals.
This scheme provides funding for established researchers and teams from any discipline who want to pursue bold and creative research ideas to deliver significant shifts in understanding related to human life, health and wellbeing.
This initiative encourages applications from organisations operating in Wales that have the potential to increase and sustain co-operation with important international regions. This may include relevant bi-lateral agreements or a relevant and specific Welsh Government strategy.
The funding bid supports small, innovative projects to improve outcomes and patient experience in bladder cancer. It aims to stimulate research and practical initiatives across primary care, clinical, and laboratory settings, focusing on early diagnosis, treatment pathways, patient support, and underrepresented areas, with preference for new or pilot work demonstrating clear, measurable impact.
The FARA Award for Innovative Mindset (AIM) supports the early stage exploration of innovative, high-risk/high-impact and potentially ground-breaking concepts in FA research that will foster new directions, bring new perspectives to the field, and address neglected issues in FA research. Studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is encouraged, but not required.
The EME programme funds ambitious studies evaluating interventions with potential to make a step-change in the promotion of health, treatment of disease and improvement of rehabilitation or long-term care. The translational research it supports covers a wide range of new and repurposed interventions, such as diagnostic or prognostic tests and decision-making tools, therapeutics or psychological treatments, medical devices, and public health initiatives delivered in the NHS
This funding supports a Horizon Europe Coordination and Support Action to strengthen EU efforts in cardiovascular health. It will finance the mapping of existing cardiovascular research and innovative solutions, identification of gaps, and development of a Strategic Research and Innovation Agenda (SRIA) for CVDs and related comorbidities. The action focuses on translating research results into implementable, personalised prevention, prediction and screening approaches, including digital, genomic and AI-based methods. Funding also supports stakeholder engagement, capacity building, integration of social sciences and humanities, and dissemination activities to inform policy and align with the future EU Cardiovascular Health plan.
Fellowship for postdoctoral medical or clinical professionals to undertake laboratory-based research into the pathogenesis and treatment of motor neurone disease (MND) and to establish their own research team to make the transition to independent investigator.
This funding supports the development of novel antiviral prophylactics and therapeutics for priority emerging and re-emerging viruses. It finances discovery, optimisation, preclinical testing, GMP production, and first-in-human safety studies, strengthening EU pandemic preparedness, regulatory readiness, and innovation capacity in line with the European Medical Countermeasures Strategy.
This funding supports early-stage clinical trials to validate innovative treatments and disease management solutions for major non-communicable diseases. It finances clinically ready interventions, digital and AI-enabled technologies, inclusive trial design, stakeholder engagement, and real-world data generation to improve care quality, scalability, and health outcomes across Europe.
The funding bid supports research on sex- and gender-specific cardiovascular disease (CVD) mechanisms to improve prevention, diagnosis, and treatment. It aims to develop tailored risk models, identify relevant determinants, exploit existing and new health data, and integrate social, cultural, and digital approaches, enhancing inclusive, innovative, and clinically impactful CVD interventions.
The funding bid supports the development of a Strategic Research and Innovation Agenda (SRIA) on cardiovascular diseases (CVDs) and related comorbidities in the EU. It aims to map existing research, identify gaps, integrate digital and personalised approaches, address sex-, gender-, and socio-demographic disparities, and guide prevention, early detection, and screening strategies through stakeholder engagement and evidence-based recommendations.
The funding bid supports research on the impact of digital technologies on the mental health of children and young adults. Projects should generate robust neurobiological and behavioral evidence, develop and test innovative digital interventions to promote responsible use, foster resilience, and prevent or mitigate mental disorders, incorporating sex-, gender-, and intersectional analyses, cohort or clinical studies, and end-user involvement.
This ongoing call seeks to fund high-quality research within specific gaps in the NIHR Public Health Research (PHR) portfolio. Commissioned calls against which NIHR has failed to fund sufficient research will remain open within this call in order to stimulate the required research activity.
This NIHR funding supports research into community-based interventions to improve veterans’ mental and physical health. It should address challenges of transition, stigma, and access through population-level approaches such as housing, employment, and coordinated care. Robust outcomes, economic evaluation, and stakeholder engagement are essential to inform policy and enhance holistic care.
This NIHR Public Health Research call invites proposals evaluating public mental health interventions to promote wellbeing or prevent mental ill-health in men. It emphasises a life‑course approach, targets health inequalities, encourages community‑level initiatives, and demands economic evaluation and involvement of people with lived experience.
The aim of this fellowship is to support talented researchers who have completed a higher research degree and demonstrated career consolidation and productivity across previous appointments. The fellowship enables researchers to lead their own research programmes, establish an independent research niche, and begin building their own research teams. It represents a key first step-change towards research independence, supporting progression to future leadership roles. Applications are welcomed from across our remit to improve human health, spanning basic research into disease mechanisms through to translational and developmental clinical research, ensuring support for high-quality research with clear potential for impact.
Support for current NIHR Incubators and new groups that operate within NIHR's remit and address an area/discipline where there is a need to build research capacity on a national level.
Sigma Theta Tau International Honour Society of Nursing - known as Sigma - is an international representative body for nurses and nursing. Its mission is to advance world health and celebrate nursing excellence in scholarship, leadership and service, and to respond to trends and issues in nursing and healthcare.
Funding is provided by Parkinson's UK through the Grants for Non-Drug Approaches scheme to support research into non-drug approaches that will play a vital part in helping people living with Parkinson's manage their daily challenges.
The funding bid supports research evaluating the clinical and cost-effectiveness of ambulation-focused rehabilitation programs for community-dwelling adults post-stroke with impaired walking. The study will assess impacts on quality of life, mental health, gait, mobility, independence, carer outcomes, and cost-effectiveness compared with usual care, considering demographic and regional variations.
Funding for independent scientific research in type 2 inflammation and its associated diseases, including atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyps.
Grants for researchers in Denmark to partner with international researchers to conduct exploratory research projects to develop tools to combat emerging and increasing threats from infectious diseases, including pathogenic fungi, novel antimicrobial resistance (AMR) tools and harnessing innate immunity.
Programme to support research projects relating to public health and social care in the UK that identify, evaluate and combine data from existing research studies to provide best evidence.
The Haleon Awards, together with the Oral & Dental Research Trust (ODRT), are small grant awards available to early career researchers to help fund research programmes into the fundamental mechanisms, prevention and management of plaque-related oral disease or tooth wear.
Fellowship funding to enable researchers to visit centres for clinical or diagnostic virology in Europe, with the aim of furthering knowledge in clinical or diagnostic virology.
The Foundation's Conference Awards for Ageing Research support allied health professionals, nurses and pharmacists who are actively involved in ageing-related research and wish to disseminate their findings at national or international conferences. The aim is to support early career researchers who do not have access to conference funds through existing grants or fellowships.
The National Cancer Institute (NCI) intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered may be used to probe cancer biology, to validate cancer targets or as the basis for optimised drugs.
The NIAAA invites applications for research projects focused on closing the treatment gap for alcohol use disorder (AUD). Priorities include improving access, appeal, and implementation of treatments, analysing cost and insurance systems, and addressing health disparities. Projects may span multiple disciplines, with up to five years’ funding.
This funding opportunity supports developing data and metadata standards for wearable technology to improve mental health research. Recipients will collaborate with manufacturers, researchers, and ethics experts to enable data integration, like DICOM for imaging. Funding depends on NIH budgets; projects may last up to four years with no budget cap.
Fellowship scheme for early career researchers and innovators looking to establish or transition to independence, or to develop their own ambitious plans within a commercial setting. Fellowships are available in any field of study covered by UK Research and Innovation.
The funding bid supports research evaluating community-level initiatives that prevent or reduce loneliness in the UK. It seeks to assess the health and health inequality impacts of interventions—including community assets, place-based approaches, social skills programs, and virtual communities—focusing specifically on loneliness rather than social isolation, to inform effective population-level strategies.
This funding supports research to develop and validate microbiome-based tools for early cancer prediction and prevention. It finances longitudinal data collection, AI-driven risk modelling, comparison with liquid biopsy tests, validation in independent cohorts, and stakeholder and citizen engagement to advance personalised, minimally invasive early detection aligned with the EU Cancer Mission.
The BAPRAS Pump Priming Fund offers a single grant each year to support pump priming clinical trial projects in the field of plastic surgery. The aim of the award is to support early feasibility work for a proposed clinical trial in support of a subsequent application for funding from the NIHR or other large funding body.
The Medical Research Council (MRC) provides experimental medicine grants to support academically-led experimental medicine projects that address gaps in current understanding of the causes, progression and treatment of human disease through experimental intervention, or challenge, in humans.
Sigma Theta Tau International Honour Society of Nursing - known as Sigma - is an international representative body for nurses and nursing. Its mission is to advance world health and celebrate nursing excellence in scholarship, leadership and service, and to respond to trends and issues in nursing and healthcare. In collaboration with the Rosemary Berkel Crisp Foundation, Sigma offers a Research Grant is to support nursing research in the critical areas of women's health, oncology and paediatrics.
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) is inviting research projects that implement early phase (Phase 0, I and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of NCI's Division of Cancer Treatment and Diagnosis (DCTD) and Office of HIV and AIDS Malignancies (OHAM). The proposed project must involve at least one clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program, and/or the HIV and AIDS Malignancies Research Programs.
This funding supports implementation research to prevent, detect and manage chronic non-communicable diseases from early childhood to young adulthood. It finances evidence-based interventions in LMICs and underserved populations, addressing social determinants of health, equitable delivery, capacity building, and policy-relevant solutions to improve lifelong non-communicable disease outcomes.
The funding bid supports the development and clinical validation of improved point-of-care diagnostic devices. It aims to optimise accuracy, usability, and affordability, meet WHO REASSURED criteria, and demonstrate added value over existing tests, with priority for resource-limited settings and high-impact infectious or emergency disease applications.
Applications for innovative research projects to test strategies to increase the reach, efficiency, effectiveness and quality of digital mental health interventions that may impact mental health outcomes, including suicide behaviours and serious mental illness.
This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. The overall goal of this NOFO is to identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans.
The purpose of this Notice of Funding Opportunity (NOFO) is to encourage applications seeking to develop the next generation of brain stimulation devices for treating mental health disorders.
This funding opportunity supports clinical trials of orphan products (phases 1–3) for rare diseases with unmet medical needs. It aims to evaluate safety and/or efficacy to support new indications or labeling changes, ultimately increasing approved treatments and advancing innovative, collaborative approaches in rare disease drug development.
Capital grants for UK-registered private sector life sciences companies for large-scale R&D projects that are primarily capital investments and dependent on the grant to proceed.
